
    
      The GORE速 HELEX速 Septal Occluder is an approved medical device indicated for the
      transcatheter closure of atrial septal defects (ASDs). The purpose of this study is to
      evaluate the long-term safety and efficacy of the GORE速 HELEX速 Septal Occluder in the
      treatment of ostium secundum atrial septal defects (ASDs). This is an FDA Condition of
      Approval Study. All subjects enrolled in this study will be followed for long-term safety and
      efficacy of the occluder device through 5 years.
    
  